Latent Tuberculosis Infection
10 questions
Learning Objectives
- Discuss the epidemiology of tuberculosis and HIV coinfection in the United States
- State the rationale for screening for latent TB in people with HIV
- Describe and compare recommended screening tests for latent TB in people with HIV
- List recommended options for the treatment of latent TB in people with HIV
- Summarize common drug interactions between medications used to treat latent TB and common antiretroviral medications
Authors
Aley G. Kalapila, MD, PhD
Aley G. Kalapila, MD, PhD
Associate Professor of Medicine
Division of Infectious Diseases
Emory University School of Medicine
Grady Health System
Associate Professor of Medicine
Division of Infectious Diseases
Emory University School of Medicine
Grady Health System
Disclosures: None
Reviewers
David H. Spach, MD
David H. Spach, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington
Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington
Disclosures: None
3rd Edition
This is a substantial revision of the original Question Bank Topic. The previous edition was titled Latent Tuberculosis Infection and available until September 1st, 2023.
CNE/CME Continuing Education
This question bank topic qualifies for:
View CE Notices
- 1 CME AMA PRA Category 1 Credit™, or
- 1 CNE contact hour (does NOT qualify for pharmacology CE for advanced practice nurses)
CNE and CME Origination: October 1st, 2017
CNE and CME Reviewed: September 1st, 2023
CNE and CME Expiration: August 31st, 2026 (3rd Edition)
View CE Notices
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5
Print Certificate
Obtain proof of CE Explore this topic in detail in the Latent Tuberculosis Infection Quick Reference,
or earn more CE for it in the Latent Tuberculosis Infection Self-Study
or earn more CE for it in the Latent Tuberculosis Infection Self-Study